Annual Drug Patent Expirations for BREVIBLOC+IN+PLASTIC+CONTAINER Brevibloc In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from three suppliers. There…
The post New patent expiration for Baxter Hl…
New patent expiration for Baxter Hlthcare drug BREVIBLOC IN PLASTIC CONTAINER Read Post »
This chart shows the pharmaceutical companies with the most powder dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most powder dosed drugs…
The post Which pharmaceutical companies have the most powder…
Which pharmaceutical companies have the most powder dosed drugs? Read Post »
Annual Drug Patent Expirations for ALPHAGAN+P Alphagan P is a drug marketed by Allergan and is included in two NDAs. It is available from one supplier. There are eight patents…
The post New patent expiration for Allergan drug ALPHAGAN P appeared first …
New patent expiration for Allergan drug ALPHAGAN P Read Post »
This chart shows the pharmaceutical companies with the most patents in Poland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug paten…
Which pharmaceutical companies have the most drug patents in Poland? Read Post »
Annual Drug Patent Expirations for EVEKEO+ODT Evekeo Odt is a drug marketed by Arbor Pharms Llc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Arbor Pharms drug EVEKEO ODT appeared first on DrugPatentW…
Annual Drug Patent Expirations for MYFEMBREE Myfembree is a drug marketed by Myovant Sciences and is included in one NDA. The generic ingredient in MYFEMBREE is estradiol; norethindrone acetate; relugolix.…
The post New patent for Myovant Sciences drug…
Annual Drug Patent Expirations for XENLETA Xenleta is a drug marketed by Nabriva and is included in two NDAs. There are four patents protecting this drug. Drug patent litigation for…
The post New patent expiration for Nabriva drug XENLETA appeared firs…
This chart shows the drugs with the most patents in Greece. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Greece? …
Which pharmaceutical drugs have the most drug patents in Greece? Read Post »
Annual Drug Patent Expirations for FASLODEX Faslodex is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent expiration for Astrazeneca drug FASLODEX appear…
New patent expiration for Astrazeneca drug FASLODEX Read Post »
Annual Drug Patent Expirations for RESCULA Rescula is a drug marketed by Sucampo Pharma Llc and is included in one NDA. There is one patent protecting this drug and one…
The post New patent expiration for Sucampo Pharma drug RESCULA appeared first on D…
New patent expiration for Sucampo Pharma drug RESCULA Read Post »
Get new actionable insights and updates from BiotechBlog
